Skip to content

Wait Less; an online brief psychological intervention to reduce waiting list distress

Wait Less: co-designing and evaluating an online self-help brief psychosocial intervention (MMW) for young people with mood-related mental health problems to reduce waiting lists in specialist children and young people’s mental health services

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55681753
Enrollment
80
Registered
2026-01-08
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression in young people aged 12 to 17 years Mental and Behavioural Disorders

Interventions

Feasibility RCT This study is a pilot trial of MyMindWorks (MMW) versus waiting as usual in 10 NHS CYPMHS within two NHS Foundation Trusts to test recruitment, retention, and research processes. The t

Sponsors

University of Cambridge
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Young people aged 12 to 17 years old 2. Recruited from the Children and Young People's Mental Health Service waitlist for treatment because of low mood or depression. Eligibility commences from the moment of allocation to the waiting list and persists until a young person chooses to leave the waiting list or is offered a treatment by the service. From prior RCT research, it has been inferred that the median age of wait-list participants in scope for MMW will be 15 years and 3 months, and 70% will be female sex as assigned at birth.

Exclusion criteria

Exclusion criteria: There are no initial participant exclusion criteria. Young people in crisis are likely to come off the waiting list so by definition will no longer be eligible. Some young people may deteriorate whilst part of the study and require active treatment from the Child and Young People's Mental Health Service, which will be monitored in terms of safety and numbers to inform sample size calculation for a definitive trial. Access to MMW would not be withdrawn should this occur, unless advised to do so by the treating practitioners practitioner. Such discussions will be carefully recorded and monitored.

Countries

England, United Kingdom

Contacts

Public ContactTamsin Ford
tjf52@cam.ac.ukNone available

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 20, 2026